Chime Biologics Received Commercial Manufacturing License Indicating the Kick-off into the Era of Commercial Production
/PRNewswire/ -- On August 2, 2022 (Beijing time), Chime Biologics, a leading CDMO that enables its partners success in biologics, announced that it has...
John Zeng National Drug Regulatory Authority National Medical Products Administration Chime Biologic Biologics Unprecedented Chime Biologics
Source: prnewswire.com